Schonfeld Strategic Advisors LLC Axsome Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 81,997 shares of AXSM stock, worth $7.96 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

81,997

Previous 58,909 39.19%

Holding current value

$7.96 Million

Previous $4.74 Million 55.36%

% of portfolio

0.05%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $1.82 Million - $2.21 Million	23,088 Added 39.19%	81,997 $7.37 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $83,661 - $102,476	-1,273 Reduced 2.12%	58,909 $4.74 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $3.24 Million - $4.56 Million	-46,660 Reduced 43.67%	60,182 $4.8 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $2.25 Million - $3.27 Million	39,144 Added 57.82%	106,842 $8.5 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $527,269 - $625,946	-7,614 Reduced 10.11%	67,698 $4.73 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $3.8 Million - $5.87 Million	64,999 Added 630.26%	75,312 $5.41 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $4.32 Million - $5.55 Million	-74,042 Reduced 87.77%	10,313 $636,000
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $1.4 Million - $2.79 Million	34,955 Added 70.76%	84,355 $6.51 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $8,077 - $15,646	-224 Reduced 0.45%	49,400 $2.2 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $920,123 - $1.98 Million	42,324 Added 579.78%	49,624 $1.9 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $173,010 - $302,147	7,300 New	7,300 $302,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $40,431 - $57,105	-1,317 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$19.91 - $68.26 $51,427 - $176,315	-2,583 Reduced 66.23%	1,317 $44,000
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $197,457 - $286,650	3,900 New	3,900 $263,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $1.36 Million - $1.71 Million	-19,886 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $362,405 - $717,180	7,267 Added 57.59%	19,886 $1.64 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $723,842 - $1.78 Million	-17,569 Reduced 58.2%	12,619 $742,000
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $1.54 Million - $9.81 Million	-92,312 Reduced 75.36%	30,188 $3.12 Million
Q3 2019 Nov 14, 2019	SELL	$20.24 - $29.16 $9.86 Million - $14.2 Million	-487,300 Reduced 79.91%	122,500 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $6.53 Million - $12.5 Million	485,300 Added 389.8%	609,800 $15.7 Million
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $327,435 - $2.03 Million	124,500 New	124,500 $1.77 Million

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.16B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Axsome Therapeutics, Inc. Transaction History